Cite
APA Citation
Wang, T., L. Li, , Huang, L., Liu, J., Zhu, D., Qin, C., Dong, J., Deng, H., Zheng, X., Tian, L., Jiang, L., Wang, W., Zhou, P., Su, M., Pu, D., Cai, X., Feng, M., Ou, X., Wang, Y., & Zhou, Q. (n.d.). 82P Preliminary analysis of tislelizumab (TIS) and chemotherapy as neoadjuvant therapy for potentially resectable stage IIIA/IIIB non-small cell lung cancer (NSCLC). Immuno-oncology technology, 16, . http://access.bl.uk/ark:/81055/vdc_100172206853.0x00000b